
### [NCIT:C4115](http://purl.obolibrary.org/obo/NCIT_C4115)
**Label:** Transitional Cell Papilloma

**Subclasses:** [NCIT:C3842](http://purl.obolibrary.org/obo/NCIT_C3842) (Urothelial Papilloma), [NCIT:C6192](http://purl.obolibrary.org/obo/NCIT_C6192) (Inverted Urothelial Papilloma), [NCIT:C4118](http://purl.obolibrary.org/obo/NCIT_C4118) (Inverted Transitional Cell Papilloma), [NCIT:C6160](http://purl.obolibrary.org/obo/NCIT_C6160) (Ureter Urothelial Papilloma), [NCIT:C5061](http://purl.obolibrary.org/obo/NCIT_C5061) (Urethral Urothelial Papilloma), [NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma), [NCIT:C39858](http://purl.obolibrary.org/obo/NCIT_C39858) (Bladder Urothelial Papilloma), [NCIT:C4528](http://purl.obolibrary.org/obo/NCIT_C4528) (Renal Pelvis Urothelial Papilloma), [NCIT:C6174](http://purl.obolibrary.org/obo/NCIT_C6174) (Ureter Inverted Papilloma), [NCIT:C6173](http://purl.obolibrary.org/obo/NCIT_C6173) (Urethral Inverted Papilloma), [NCIT:C6187](http://purl.obolibrary.org/obo/NCIT_C6187) (Renal Pelvis Inverted Papilloma), 

**Class expressions from DL-Learner:**

- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CL:1001428](http://purl.obolibrary.org/obo/CL_1001428) (bladder urothelial cell))) 58.33%
- [NCIT:C54557](http://purl.obolibrary.org/obo/NCIT_C54557) (Renal Pelvis Urothelial Cell) 54.17%
- [NCIT:C12866](http://purl.obolibrary.org/obo/NCIT_C12866) (Transitional Cell) 54.17%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 54.17%
- Thing 52.82%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) 49.16%
- [CL:0000244](http://purl.obolibrary.org/obo/CL_0000244) (transitional epithelial cell) 49.16%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 49.16%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 49.16%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 49.16%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 49.16%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 49.16%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40063](http://purl.obolibrary.org/obo/NCIT_C40063) (Ovarian Low Grade Endometrioid Stromal Sarcoma))) 49.16%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation))) 49.16%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C40043](http://purl.obolibrary.org/obo/NCIT_C40043) (Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei))) 49.16%


